Manufacturer
Novo Nordisk NDC Codes
Finished products listed with the FDA under labeler names that contain “Novo Nordisk”.
Products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-3685 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-3696 |
| NovoSeven RTcoagulation factor viia (recombinant) | — | Kit | Novo Nordisk | 0169-7010 |
| NovoSeven RTcoagulation factor viia (recombinant) | — | Kit | Novo Nordisk | 0169-7020 |
| NovoSeven RTcoagulation factor viia (recombinant) | — | Kit | Novo Nordisk | 0169-7040 |
| NovoSeven RTcoagulation factor viia (recombinant) | — | Kit | Novo Nordisk | 0169-7050 |
| NovoSeven RTcoagulation factor viia (recombinant) | — | Kit | Novo Nordisk | 0169-7201 |
| NovoSeven RTcoagulation factor viia (recombinant) | — | Kit | Novo Nordisk | 0169-7202 |
| NovoSeven RTcoagulation factor viia (recombinant) | — | Kit | Novo Nordisk | 0169-7205 |
| NovoSeven RTcoagulation factor viia (recombinant) | — | Kit | Novo Nordisk | 0169-7208 |
| Ozempicoral semaglutide | Semaglutide 4 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-1704 |
| Ozempicoral semaglutide | Semaglutide 9 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-1709 |
| Ozempicoral semaglutide | Semaglutide 1.5 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-1715 |
| Ozempicsemaglutide | Semaglutide 1.34 mg/mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4130 |
| Ozempicsemaglutide | Semaglutide .68 mg/mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4181 |
| Ozempicsemaglutide | Semaglutide 2.68 mg/mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4772 |
| Rebinyncoagulation factor ix recombinant, glycopegylated | — | Kit | Novo Nordisk | 0169-7901 |
| Rebinyncoagulation factor ix recombinant, glycopegylated | — | Kit | Novo Nordisk | 0169-7902 |
| Rebinyncoagulation factor ix recombinant, glycopegylated | — | Kit | Novo Nordisk | 0169-7903 |
| Rebinyncoagulation factor ix recombinant, glycopegylated | — | Kit | Novo Nordisk | 0169-7905 |
| Rivflozanedosiran | Nedosiran sodium 160 mg/mL | Injection, SolutionSubcutaneous | Novo Nordisk | 0169-5306 |
| Rivflozanedosiran | Nedosiran sodium 128 mg/.8mL | Injection, SolutionSubcutaneous | Novo Nordisk | 0169-5307 |
| Rivflozanedosiran | Nedosiran sodium 80 mg/.5mL | Injection, SolutionSubcutaneous | Novo Nordisk | 0169-5308 |
| Rybelsusoral semaglutide | Semaglutide 3 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-4303 |
| Rybelsusoral semaglutide | Semaglutide 7 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-4307 |